AIDS and Legal Access to Sterile Drug Injection Equipment

Don Des Jarlais, Samuel R. Friedman

Research output: Contribution to journalArticle

Abstract

Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.

Original languageEnglish (US)
Pages (from-to)42-65
Number of pages24
JournalThe ANNALS of the American Academy of Political and Social Science
Volume521
Issue number1
DOIs
StatePublished - Jan 1 1992

Fingerprint

drug
risk behavior
sales
drug use
human being

ASJC Scopus subject areas

  • Sociology and Political Science
  • Social Sciences(all)

Cite this

AIDS and Legal Access to Sterile Drug Injection Equipment. / Des Jarlais, Don; Friedman, Samuel R.

In: The ANNALS of the American Academy of Political and Social Science, Vol. 521, No. 1, 01.01.1992, p. 42-65.

Research output: Contribution to journalArticle

@article{282856d1cb1045f69775cb50391a217a,
title = "AIDS and Legal Access to Sterile Drug Injection Equipment",
abstract = "Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.",
author = "{Des Jarlais}, Don and Friedman, {Samuel R.}",
year = "1992",
month = "1",
day = "1",
doi = "10.1177/0002716292521001004",
language = "English (US)",
volume = "521",
pages = "42--65",
journal = "Annals of the American Academy of Political and Social Science",
issn = "0002-7162",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - AIDS and Legal Access to Sterile Drug Injection Equipment

AU - Des Jarlais, Don

AU - Friedman, Samuel R.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.

AB - Legal access to sterile injection equipment has been a primary strategy for preventing the acquired immune deficiency syndrome (AIDS) among persons who inject illicit drugs in almost all developed countries. This strategy has remained highly controversial in the United States, with only a small number of localities adopting it. This article reviews different techniques of providing legal access—over-the-counter sales and syringe exchanges—research design issues relevant to evaluating legal-access programs, and the findings from the large number of studies conducted to date. The findings are consistent in showing no increase in illicit drug use related to legal access and decreases in AIDS risk behavior related to legal-access programs. The design of legal-access programs for maximal impact and the ultimate effect of the decreases in AIDS risk behavior on transmission of the human immunodeficiency virus (HIV) remain to be determined.

UR - http://www.scopus.com/inward/record.url?scp=84976936304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976936304&partnerID=8YFLogxK

U2 - 10.1177/0002716292521001004

DO - 10.1177/0002716292521001004

M3 - Article

AN - SCOPUS:84976936304

VL - 521

SP - 42

EP - 65

JO - Annals of the American Academy of Political and Social Science

JF - Annals of the American Academy of Political and Social Science

SN - 0002-7162

IS - 1

ER -